-
- Chong Cui
- ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital State Key Laboratory of Medical Neurobiology Institutes of Biomedical Sciences Fudan University Shanghai China
-
- Qi Yao
- Department of Otorhinolaryngology Chinese and Western Medicine Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan China
-
- Di Zhang
- Department of Otolaryngology The Third People’s Hospital of Shenzhen Longgang District Shenzhen China
-
- Yu Zhao
- ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital State Key Laboratory of Medical Neurobiology Institutes of Biomedical Sciences Fudan University Shanghai China
-
- Kun Zhang
- ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital State Key Laboratory of Medical Neurobiology Institutes of Biomedical Sciences Fudan University Shanghai China
-
- Eric Nisenbaum
- Department of Otolaryngology University of Miami Miller School of Medicine Miami Florida USA
-
- Pengyu Cao
- ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital State Key Laboratory of Medical Neurobiology Institutes of Biomedical Sciences Fudan University Shanghai China
-
- Keqing Zhao
- ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital State Key Laboratory of Medical Neurobiology Institutes of Biomedical Sciences Fudan University Shanghai China
-
- Xiaolong Huang
- Department of Otorhinolaryngology Chinese and Western Medicine Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan China
-
- Dewen Leng
- Department of Otorhinolaryngology Chinese and Western Medicine Hospital of Tongji Medical College Huazhong University of Science and Technology Wuhan China
-
- Chunhan Liu
- Department of Otolaryngology The Third People’s Hospital of Shenzhen Longgang District Shenzhen China
-
- Ning Li
- Department of Infectious Disease Huashan Hospital Fudan University Shanghai China
-
- Yan Luo
- Department of Hospital‐Acquired Infection Control Eye and ENT Hospital Fudan University Shanghai China
-
- Bing Chen
- ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital State Key Laboratory of Medical Neurobiology Institutes of Biomedical Sciences Fudan University Shanghai China
-
- Roy Casiano
- Department of Otolaryngology University of Miami Miller School of Medicine Miami Florida USA
-
- Donald Weed
- Department of Otolaryngology University of Miami Miller School of Medicine Miami Florida USA
-
- Zoukaa Sargi
- Department of Otolaryngology University of Miami Miller School of Medicine Miami Florida USA
-
- Fred Telischi
- Department of Otolaryngology University of Miami Miller School of Medicine Miami Florida USA
-
- Hongzhou Lu
- Department of Infectious Diseases Shanghai Public Health Clinical Center Shanghai China
-
- James C. Denneny
- American Academy of Otolaryngology–Head and Neck Surgery Alexandria Virginia USA
-
- Yilai Shu
- ENT Institute and Otorhinolaryngology Department of the Affiliated Eye and ENT Hospital State Key Laboratory of Medical Neurobiology Institutes of Biomedical Sciences Fudan University Shanghai China
-
- Xuezhong Liu
- Department of Otolaryngology University of Miami Miller School of Medicine Miami Florida USA
抄録
<jats:sec><jats:title>Objective.</jats:title><jats:p>To describe coronavirus disease 2019 (COVID‐19) patient presentations requiring otolaryngology consultation and provide recommendations for protective measures based on the experience of ear, nose, and throat (ENT) departments in 4 Chinese hospitals during the COVID‐19 pandemic.</jats:p></jats:sec><jats:sec><jats:title>Study Design.</jats:title><jats:p>Retrospective case series.</jats:p></jats:sec><jats:sec><jats:title>Setting.</jats:title><jats:p>Multicenter.</jats:p></jats:sec><jats:sec><jats:title>Subjects and Methods.</jats:title><jats:p>Twenty hospitalized COVID‐19 patients requiring ENT consultation from 3 designated COVID‐19 hospitals in Wuhan, Shanghai, and Shenzhen were identified. Data on demographics, comorbidities, COVID‐19 symptoms and severity, consult reason, treatment, and personal protective equipment (PPE) use were collected and analyzed. Infection control strategies implemented for ENT outpatients and emergency room visits at the Eye and ENT Hospital of Fudan University were reported.</jats:p></jats:sec><jats:sec><jats:title>Results.</jats:title><jats:p>Median age was 63 years, 55% were male, and 95% were in severe or critical condition. Six tracheotomies were performed. Posttracheotomy outcomes were mixed (2 deaths, 2 patients comatose, all living patients still hospitalized). Other consults included epistaxis, pharyngitis, nasal congestion, hyposmia, rhinitis, otitis externa, dizziness, and tinnitus. At all hospitals, powered air‐supply filter respirators (PAPRs) were used for tracheotomy or bleeding control. PAPR or N95‐equivalent masks plus full protective clothing were used for other complaints. No inpatient ENT providers were infected. After implementation of infection control strategies for outpatient clinics, emergency visits, and surgeries, no providers were infected at the Eye and ENT Hospital of Fudan University.</jats:p></jats:sec><jats:sec><jats:title>Conclusions and Relevance.</jats:title><jats:p>COVID‐19 patients require ENT consultation for many reasons, including tracheotomy. Otolaryngologists play an indispensable role in the treatment of COVID‐19 patients but, due to their work, are at high risk of exposure. Appropriate protective strategies can prevent infection of otolaryngologists.</jats:p></jats:sec>
収録刊行物
-
- Otolaryngology–Head and Neck Surgery
-
Otolaryngology–Head and Neck Surgery 163 (1), 121-131, 2020-05-12
Wiley